Scaling up preventive TB treatment for people with HIV/AIDS and household contacts of newly diagnosed TB patients could save nearly 850,000 lives by 2035, experts estimate.
The agreement between Johnson & Johnson and the Stop TB Partnership will make cheaper, generic versions of bedaquiline available in low- and middle-income nations.
The first clinical trial of a 3-month treatment regimen for tuberculosis is closing enrollment because of a high rate of unfavorable outcomes.
The Bill & Melinda Gates Foundation and Wellcome will provide $550 million for a phase 3 trial of a vaccine to prevent tuberculosis.
The pooled proportion of cases treated successfully was 44%, well below the WHO target success rate of 75%.
The authors say the oral BPaL regimen has "transformed" treatment for drug-resistant tuberculosis.
Ahead of a UN meeting, the executive director of the Stop TB Partnership discusses why the world hasn't done more to combat tuberculosis, and why she's hopeful for the future.
Screening frequency could range from one-time only screening among people at low risk for tuberculosis exposure to annual screening among those at continued risk.
To mark the observance, there were useful status reports and news of a high-level group that will lead a stronger push against TB in high-burden countries.
The rise follows a decline earlier in the pandemic, which may have contributed to delayed or missed diagnoses.